Research Articles | Page 20 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Management of aplastic anemia after failure of frontline immunosuppression Jul 2019 Expert Review of Hematology Aplastic Anemia
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes Sep 2020 Blood Myelodysplastic Syndromes (MDS)
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial Sep 2024 The Lancet Haematology Myelodysplastic Syndromes (MDS)
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial Jul 2024 Lancet Hematology Myelodysplastic Syndromes (MDS)
Luspatercept use for lower risk myelodysplastic syndromes: Active but not enough Jun 2023 American Journal of Hematology Myelodysplastic Syndromes (MDS)
Luspatercept in the treatment of lower-risk myelodysplastic syndromes Jan 2021 Future Oncology (London, England) Myelodysplastic Syndromes (MDS)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Jan 2020 The New England Journal of Medicine Myelodysplastic Syndromes (MDS)
Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies Mar 2024 Expert Opinion on Biological Therapy Myelodysplastic Syndromes (MDS)
Lowering the boom on lower-risk myelodysplastic syndromes Dec 2019 Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes Aug 2020 Cancer Myelodysplastic Syndromes (MDS)